Saunders M E, Sherwood W G, Duthie M, Surh L, Gravel R A
Am J Hum Genet. 1982 Jul;34(4):590-601.
We report here the expression of biotin-responsive multiple carboxylase deficiency in cultured lymphoblasts of a patient whose fibroblasts belong to the bio genetic complementation group. Cultured lymphoblasts from the patient lost propionyl-CoA carboxylase (PCC) and beta-methylcrotonyl-CoA carboxylase (MCC) activities at a faster rate than normal cells when grown in biotin-deficient medium. Recovery of normal PCC and MCC activities, which was independent of protein synthesis, required a 2,500-fold higher biotin concentration than that required by normal lymphoblasts. Holocarboxylase synthetase activity was detected in cell-free extracts through the biotinylation of endogenous apo-PCC in the presence of ATP to form active holo-PCC. While the apo-PCC in extracts of normal biotin-starved lymphoblasts could be activated to 28% of maximal activity, extracts of patient lymphoblasts did not exhibit any ATP and biotin-dependent increase in PCC activity. A normal cell extract, cleared of apocarboxylases by immunoprecipitation, stimulated the PCC activity of a patient cell extract 20-fold. These results indicate that the apoenzyme in bio cells is normal and that the defect lies in the holocarboxylase synthetase.
我们在此报告了一名患者培养的淋巴母细胞中生物素反应性多种羧化酶缺乏症的表达情况,该患者的成纤维细胞属于生物遗传互补组。当在生物素缺乏的培养基中生长时,来自该患者的培养淋巴母细胞失去丙酰辅酶A羧化酶(PCC)和β-甲基巴豆酰辅酶A羧化酶(MCC)活性的速度比正常细胞更快。恢复正常的PCC和MCC活性,这与蛋白质合成无关,所需的生物素浓度比正常淋巴母细胞高2500倍。通过在ATP存在下对内源性脱辅基PCC进行生物素化以形成活性全酶PCC,在无细胞提取物中检测到全羧化酶合成酶活性。虽然正常生物素饥饿的淋巴母细胞提取物中的脱辅基PCC可以被激活至最大活性的28%,但患者淋巴母细胞提取物未表现出任何ATP和生物素依赖性的PCC活性增加。通过免疫沉淀清除脱辅基羧化酶的正常细胞提取物,刺激患者细胞提取物的PCC活性增加了20倍。这些结果表明生物细胞中的脱辅基酶是正常的,缺陷在于全羧化酶合成酶。